Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Shares of Intuitive Surgical Inc. rallied 9.5% Wednesday to lead S&P 500 gainers, after the maker of robotic surgical equipment updated guidance for fourth-quarter sales with some bullish numbers, buoyed by a recovery in China.

Intuitive Surgical leads S&P 500 gainers as analysts welcome bullish guidance for 2024

U.S. equities were up at midday ahead of key inflation data and earnings reports due later in the week. The Dow, S&P 500, and Nasdaq were all in the green.

Midday Movers: Intuitive Surgical Surges on Strong Results, Amex Falls on Downgrade

Shares of Intuitive Surgical (ISRG) moved sharply higher Wednesday as the maker of the da Vinci robotic surgical device said it anticipates better-than-expected results on a rise in surgical procedures.

Intuitive Surgical Stock Jumps After Company Reports Strong Preliminary Q4 Results

Blackrock Inc

United States Natural Gas Fund LP

Here's our daily look at three charts connected to recent news-driven price moves, with important technical levels to eye.

3 Charts For Investors to Watch Wednesday: Intuitive, BlackRock, US Natural Gas Fund

ISRG stock homed in on a new buy point Wednesday, after boosting expectations for its fourth-quarter revenue.

ISRG Stock Jumps On Q4 Revision, New Buy Point In Play

Intuitive Surgical (NASDAQ: ISRG) stock price has silently outperformed the market in the past decade. It has risen by over 700% since 2014 while the benchmark S&P 500 (SPX) index has risen by about 150% in the same period.

Intuitive Surgical (ISRG) stock: not cheap but a buy anyway

Shares of Intuitive Surgical Inc. ISRG, +0.52% rallied after hours on Tuesday after the maker of robotic surgical equipment said it expected fourth-quarter sales that were above Wall Street's expectations, helped by a recovery in China. The company reported preliminary fourth-quarter revenue of around $1.93 billion, up 17% and above FactSet forecasts for $1.87 billion.

Intuitive Surgical stock rallies on sales forecast, as demand for robot surgeons rises

SUNNYVALE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2023 financial results ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024.

Intuitive Announces Preliminary Fourth Quarter and Full Year 2023 Results

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $328.86, marking a +1.97% move from the previous day.

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

JPMorgan Chase & Co

Coca-Cola

Arguably, one of the biggest tech stories of 2023 was the rise of generative AI and ChatGPT. Google the words “generative AI,” and you get 368 million results.

AI's Top Picks: 3 Best Stocks Across Key Sectors for 2024

NVIDIA

UiPath

The global robotics industry will continue to pick up steam, making it a great time to consider the best robotics stocks to buy. As we step into 2024, the potential for growth in the robotics industry remains substantial.

3 Robotics Stocks That Will Go the Distance in 2024

Zebra Technologies

As the world stands on the cusp of an AI-driven revolution, the investment world buzzes with anticipation, seeking the hidden gems — the stealthy AI stocks — that could potentially unlock immense wealth in 2024. Explore the trio of technological shifters, each wielding its arsenal of innovation in artificial intelligence ( AI ).

3 Stealth AI Stocks to Ride 2024's Biggest Trend to Riches

CRISPR Therapeutics

Vertex Pharmaceuticals

Betting on healthcare's future via healthcare stocks is one of the safest long-term bets you can make. Though changes and advances happen rapidly, healthcare is one industry that is here to stay.

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $330.98, signifying a -1.89% move from its prior day's close.

Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market

Costco

Consumers need quality healthcare and affordable goods in any economic environment. Intuitive Surgical is profitable and revenue is rising, while its addressable market is growing.

2 Time-Tested Stocks to Buy Right Now That Could Make You Richer in 2024

Despegar.com

Perion Network

Certain stocks stand poised as potential catalysts for generating colossal wealth in the bustling investment arena. Imagine a journey into the pulsating realms of three distinct industries—advertising technology, surgical innovation, and the Latin American travel market—where three companies emerge as titans.

Portfolio Powerhouses: 3 Stocks That Could Make You a Millionaire by 2026

Fiverr

The gig economy and healthcare industry are booming. Fiverr is increasing its value proposition for buyers and sellers.

2 Magnificent Growth Stocks to Buy With $1,000 Right Now for 2024

In the rapidly evolving world of technology, staying ahead of the curve is crucial for savvy investors. So, as automation expands, top robotics stocks have emerged as a captivating opportunity in the technological investment landscape.

Robotics Revolution: 3 Stocks Engineering the Future

Palo Alto Networks

The market is knocking on the door of record highs. But a correction will come at some point.

3 Stocks I Want to Buy if the Market Crashes Again

MercadoLibre

$1 million may not be as impressive a number as it once was, but it is still a commendable investment goal. Turning $50,000 into $1 million is no small feat.

The Big Leap: 3 Long-Term Growth Stocks to Turn $50k to $1M

ISRG started chopping higher immediately after our recommendation.

Medical Device Stock Delivered Christmas Treat to Bulls

Teladoc

If you had to bet on two “big picture” sectors to invest in for the long haul, you can't go wrong with technology or healthcare. Both are omnipresent and, in their own ways, on the cutting edge of global innovation that cement their longevity as investable opportunities.

3 Healthcare Technology Stocks to Improve Lives in 2024

Allegheny Technologies

Brainsway

Concentrix Corporation 

Ferroglobe

Roblox

Viper Energy Partners LP

A cadre of quietly thriving companies has been making significant strategic strides in a market where giants often grab the spotlight. These under-the-radar stocks are positioning themselves for a remarkable breakthrough by 2025.

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough

Deere & Company

Teradyne

When it comes to forward-looking investment ideas, few are as relevant as robotics stocks. It's really all in the numbers.

3 Robotics Stocks to Automate Your Future in 2024

The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $328.42, representing a +1.25% change from its previous close.

News for Intuitive Surgical Stock (ISRG)